New drug OKd for late-stage breast cancer

WASHINGTON, Feb. 23 (UPI) -- The U.S. Food and Drug Administration approved Kadcyla, a new drug for patients with HER2-positive, late-stage or metastatic breast cancer.
Source: Health News - UPI.com - Category: Consumer Health News Source Type: news